Grip strength may predict cancer patient survival
NCT ID NCT07167082
First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This completed study looked at 130 hospitalized cancer patients to see if hand grip strength could predict short-term outcomes like death within 30 days, ICU admission, or hospital readmission. Researchers measured grip strength within 24 hours of admission using a simple, non-invasive device. The goal is to find a quick, low-cost way to identify patients who may need extra support during their hospital stay.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could provide doctors with a simple, low-cost tool to identify hospitalized cancer patients at higher risk of complications or death within 30 days.
What could go wrong
This is an observational study, not a treatment trial. It only looks for associations, so it cannot prove that grip strength directly causes better or worse outcomes. Results may not apply to all cancer types or settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Etlik City Hospital, Medical Oncology Department
Ankara, Yenimahalle, 06210, Turkey (Türkiye)